✦ LIBER ✦

Enhanced sensitivity of non-small cell lung cancer cell lines to flavopiridol following cisplatin or gemcitabine-imposed S phase delay

✍ Scribed by Matranga, C.B; Supko, J.G; Shapiro, G.I

Book ID: 118570149
Publisher: Elsevier Science
Year: 2000
Tongue: English
Weight: 109 KB
Volume: 29
Category: Article
ISSN: 0169-5002
DOI: 10.1016/s0169-5002(00)80604-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cisplatin and gemcitabine first-line che

Cisplatin and gemcitabine first-line chemotherapy followed by maintenance gemcitabine or best supportive care in advanced non-small cell lung cancer: A phase III trial

✍ Brodowicz, Thomas; Krzakowski, Maciej; Zwitter, Matjaz; Tzekova, Valentina; Raml 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 237 KB

Randomised multicenter phase II study of

Randomised multicenter phase II study of two schedules of docetaxel and gemcitabine or cisplatin/gemcitabine followed by docetaxel as first line treatment for advanced non-small cell lung cancer

✍ Novello, Silvia; Falcone, Alfredo; Crinò, Lucio; Rinaldi, Massimo; Nardi, Mario; 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 360 KB

Docetaxel/gemcitabine or cisplatin/gemci

Docetaxel/gemcitabine or cisplatin/gemcitabine followed by docetaxel in the first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC): results of a multicentre randomized phase II trial

✍ D. Binder; H. Schweisfurth; C. Grah; C. Schäper; B. Temmesfeld-Wollbrück; G. Sie 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 340 KB

Phase III Trial of Cisplatin Plus Gemcit

Phase III Trial of Cisplatin Plus Gemcitabine With Either Placebo or Bevacizumab As First-Line Therapy for Nonsquamous Non-Small-Cell Lung Cancer: AVAiL

✍ Reck, M.; von Pawel, J.; Zatloukal, P.; Ramlau, R.; Gorbounova, V.; Hirsh, V.; L 📂 Article 📅 2009 🏛 American Society of Clinical Oncology 🌐 English ⚖ 190 KB

17 Phase II trial of gemcitabine plus ci

17 Phase II trial of gemcitabine plus cisplatin in patients with locally advanced or metastatic non-small-cell lung cancer: Two year follow-up result

✍ Ryu, Jeong-Seon; Kim, Se-Kyu; Kim, Young-Chul; Park, Jae-Yong; Jung, Eun-Taik; J 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 183 KB

Randomized, Phase III Study of Gemcitabi

Randomized, Phase III Study of Gemcitabine or Erlotinib Maintenance Therapy Versus Observation, With Predefined Second-Line Treatment, After Cisplatin-Gemcitabine Induction Chemotherapy in Advanced Non-Small-Cell Lung Cancer

✍ Perol, M.; Chouaid, C.; Perol, D.; Barlesi, F.; Gervais, R.; Westeel, V.; Crequi 📂 Article 📅 2012 🏛 American Society of Clinical Oncology 🌐 English ⚖ 264 KB